M. Devillers

University of Liège

Papers

1

Total Citations

19

H-Index

1

About

Dr. M. Devillers is a leading clinical researcher in radiation oncology, with a primary focus on stereotactic body radiotherapy (SBRT) for lung tumors. Their most cited work, a 2017 study on CyberKnife robotic SBRT, reports clinical outcomes for 130 patients with primary and secondary lung malignancies, demonstrating the technique's efficacy and safety. This research has been cited 19 times, underscoring its influence in refining non-invasive treatment protocols for both early-stage lung cancer and metastatic disease. Dr. Devillers’ contributions have helped establish SBRT as a standard option for patients who are not surgical candidates, improving local control rates while minimizing toxicity. Their work is particularly notable for its comprehensive analysis of diverse tumor types, including T1-3 primary cancers and recurrent lesions, providing critical data for personalized treatment planning. Through this landmark study, Dr. Devillers has advanced the field of radiation oncology, offering clinicians evidence-based guidance for managing complex lung tumors with robotic precision.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Clinical outcomes of 130 patients with primary and secondary lung tumors treated with Cyberknife robotic stereotactic body radiotherapy
19 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University of Liège

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago